Global Facial Injectable Market Size, Share, Forecast Report, 2020-2027

The report provides rational insights along with historical and forecast data to aid in better understanding of the Global Facial Injectable Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of the Facial Injectable market. This study also provides a detailed overview of the opportunities along with the current trends observed in the target market.

The global facial injectable market size was valued at USD 8.88 billion in 2019 and is expected to exhibit a CAGR of 11.8% during the forecast period. Increasing consciousness regarding physical appearance among consumers coupled with growing geriatric population is anticipated to drive the growth. Furthermore, increasing shift from invasive to minimally invasive procedures and advancements in facial rejuvenation is expected to support market growth.

Factors like, rising consciousness about external appearance among young and old individuals and rising awareness regarding the availability of various products and procedures, attributed to increasing globalization and social media influence are projected to further fuel the market growth. Consumers, these days, are well informed about cosmetic products due to awareness created by traditional as well as by social media, thus, positively influencing the consumer purchasing decisions. Personalized products are gaining traction across the globe as consumers demand products that are unique and can enhance their personality.

In addition, growing importance of medical aesthetics coupled with increasing spending on aesthetic procedures is expected to fuel the market growth. For instance, according to statistics reported by the American Society for Aesthetic Plastic Surgery (ASAPS), Americans spent nearly USD 13.5 billion on surgical and nonsurgical aesthetic procedures in 2015 and more than USD 15.0 billion in 2016. Thus, increasing beauty consciousness amongst consumers coupled with increasing spending over aesthetic procedures is anticipated to propel market growth over the forecast period.

Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to the American Society of Plastic Surgeons (ASPS), in U.S, nearly 17.7 million minimally invasive and surgical cosmetic procedures were performed in 2018, out of which nearly 15.9 million procedures were minimally invasive. Thus, increasing adoption of minimally invasive surgeries, coupled with availability of a wide range of such treatment options, is driving the facial injectables market growth.

As per the data published by the CIA World FactBook, about 40.96% of the total German population was aged between 25 to 54 years and around 14.23% of the population was aged between 55 to 65 years in 2016. Similarly, approximately 48.42% of the total population of China was aged between 25 to 54 years in 2016. The elderly population is prone to skin diseases as with age, the skin wrinkles and loses elasticity. Thus, these countries form the key target population for aesthetic surgeries and are expected to push the demand for facial injectables across the world.

On the contrary, adverse effects, such as allergic reactions, nausea, rash, and neck and back pain coupled with legal and regulatory issues and safety concerns of botulinum toxin type A (pose high risk to patient safety) are anticipated to impede market growth in the forthcoming years.

The report covers major players operating in the market along with the key strategies implemented to achieve a competitive edge against a majority of the vendors which provides a competitive outlook of the industry. The competitive landscape further includes details about different players and their position on a global and a local level is also explained in detail in this compiled study. These insights were prepared through mapping business strategies and products that offer high revenue generation capacities. Key players of the global Facial Injectable market are included as given below:

Some of the major players include ALLERGAN; Ipsen; Merz Pharma; Suneva Medical, Inc.; Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited; Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; and Galderma S.A. These players focus on growth strategies, such as new product launches, partnerships, mergers and acquisitions, and regional expansions. For instance, in January 2017, ALLERGAN launched Juvéderm Volite, a hyaluronic acid injectable gel used to smoothen face lines, neck, décolletage, and hands in adults.

The global Facial Injectable market has been segmented as below:

• Product 

  • Collagen

  • Hyaluronic Acid (HA)

  • Botulinum Toxin Type A

  • Calcium Hydroxylapatite (CaHA)

  • Polymer Fillers

    • Polymethylmethacrylate Beads (PMMA Microspheres)

    • Poly-L-Lactic Acid (PLLA)

• Application 

  • Aesthetics

  • Therapeutics

• Global Facial Injectable Market by Region

• North America
• Europe
• Asia Pacific
• Rest of the World

Reasons to Purchase this Report:

Estimates Facial Injectable development trends with SWOT analysis

• Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players
• Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion
• Market dynamics scenario, along with growth opportunities for players in the years to come
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the mentioned forecast period
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects